NurseJet
Back to Discover
Systematic ReviewResearchPatient Education

APOE ε4 was more common with subjective cognitive decline than normal cognition

Journal of neurology (PubMed)Aug 30, 2026

AI-summarized from the linked source. Educational brief, not medical advice.

Brief summary

A meta-analysis found APOE ε4 carriage was more prevalent in people with subjective cognitive decline than in cognitively normal groups, but less prevalent than in mild cognitive impairment.

What NurseJet pulled from the source

Forty-nine studies were included. Pooled APOE ε4 carrier prevalence was 28.3% in subjective cognitive decline, 41.0% in mild cognitive impairment, and 22.0% in cognitively normal groups. The odds of carriage were higher with subjective cognitive decline than normal cognition (OR 1.28), but substantial heterogeneity limits individual interpretation.

Why this matters for nurses

Patients may interpret memory concerns or genetic results as proof of Alzheimer disease. Nurses can reinforce that subjective symptoms and APOE status are risk information, support structured cognitive assessment, and route concerning change for clinical evaluation.

Bedside takeaway

Treat APOE ε4 as risk information, not a diagnosis or an individual prediction of cognitive decline.

Key takeaways

  • The quantitative synthesis included 49 studies using standardized subjective-cognitive-decline criteria.
  • Pooled APOE ε4 carrier prevalence was 28.3% with subjective cognitive decline and 22.0% with normal cognition.
  • APOE ε4 carriage was more prevalent in mild cognitive impairment than in subjective cognitive decline.
  • Age and education contributed to heterogeneity, so genotype alone does not establish an individual's diagnosis or trajectory.

Practice implications

  • Document the patient's reported cognitive change, onset, functional effects, medication concerns, mood, sleep, and collateral history when available. Escalate acute change urgently and route persistent concerns through the approved cognitive-evaluation pathway without treating APOE status as a diagnosis.

Limitations & cautions

  • The analysis pooled heterogeneous cohorts, and age and education contributed to variation. Prevalence and association estimates do not show that APOE ε4 causes subjective decline or predict which individual will progress to mild cognitive impairment or dementia.
  • AI-summarized from the linked source. Review the original article before applying to practice.

Citations

Exact source links

Public citations are filtered to exact credible source pages. Homepage-only or invalid links stay in admin review and are not shown here.

Journal of neurology (PubMed)

Journal of neurology (PubMed). APOE in subjective cognitive decline: a systematic review and meta-analysis.

Open original source

https://pubmed.ncbi.nlm.nih.gov/42669099/

Professional education only

This summary does not replace clinical judgment, facility policy, provider orders, or official guidelines. Verify practice changes against the original source and local protocol.

Related briefs

More updates for this clinical area

Back to Discover

Pediatric emergency care (PubMed)

A double-blind randomized trial found no reduction in vomiting or faster oral tolerance with intravenous pantoprazole versus placebo in children with acute gastroenteritis and persistent vomiting after ondansetron.

PedsEmergencyAI summaryReview source

Journal of neurosurgical anesthesiology (PubMed)

A five-center randomized trial found similar rescue-opioid use and moderate-to-severe PACU pain with dexmedetomidine-based opioid-sparing analgesia and fentanyl-based analgesia during elective craniotomy for brain tumors.

EmergencyICUAI summaryReview source

Journal of the American Medical Directors Association (PubMed)

A prospective Dutch nursing-home cohort found clinically important differences in illness burden across respiratory viruses, with influenza and human metapneumovirus standing out.

GeriatricsMed-SurgAI summaryReview source